Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. NOVO
  4. NOVO — Januar 2025

NOVO — Januar 2025

Planlagt Fastgjort Låst Flyttet NOVO
233 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • P Offline
    P Offline
    ProinvestorNEWS
    wrote on sidst redigeret af
    #177

    Novos nye håb viser vægttab på 22 pct. - aktien tordner op https://proinvestor.com/investornyt/1269019/novos-nye-hab-viser-vaegttab-pa-22-pct-aktien-tordner-op

    1 Reply Last reply
    0
    • P Offline
      P Offline
      ProinvestorNEWS
      wrote on sidst redigeret af
      #178

      Novo imponerer med vægttabsdata: "Det her kan vende stemningen i aktien" https://proinvestor.com/investornyt/1269021/novo-imponerer-med-vaegttabsdata-det-her-kan-vende-stemningen-i-aktien

      1 Reply Last reply
      0
      • U Offline
        U Offline
        UlrikChristiansen8
        wrote on sidst redigeret af
        #179

        hvad var konsensus får disse data?

        1 Reply Last reply
        0
        • U Offline
          U Offline
          UlrikChristiansen8
          wrote on sidst redigeret af
          #180

          for*

          1 Reply Last reply
          0
          • StockBullS Offline
            StockBullS Offline
            StockBull
            wrote on sidst redigeret af
            #181

            Fed nyhed, så starter de vel nok snart produktion i Kalundborg. Måske inden for kommende 12 mdr

            1 Reply Last reply
            0
            • S Offline
              S Offline
              Sukkeralf
              wrote on sidst redigeret af
              #182

              fase 1/2 data

              1 Reply Last reply
              0
              • P Offline
                P Offline
                ProinvestorNEWS
                wrote on sidst redigeret af
                #183

                Sydbank om Novo: Fuldstændig fair kursreaktion på stærke vægttabsdata https://proinvestor.com/investornyt/1269139/sydbank-om-novo-fuldstaendig-fair-kursreaktion-pa-staerke-vaegttabsdata

                1 Reply Last reply
                0
                • P Offline
                  P Offline
                  ProinvestorNEWS
                  wrote on sidst redigeret af
                  #184

                  Novos markedsværdi steg 183 mia. kr. efter stærke fedmedata https://proinvestor.com/investornyt/1269198/novos-markedsvaerdi-steg-183-mia-kr-efter-staerke-fedmedata

                  1 Reply Last reply
                  0
                  • K Offline
                    K Offline
                    koden
                    wrote on sidst redigeret af
                    #185

                    endte "kun" 7% oppe

                    1 Reply Last reply
                    0
                    • J Offline
                      J Offline
                      JKY_VH
                      wrote on sidst redigeret af
                      #186

                      jeg hæfter mig ved "vendingen" og 7% er ikke dårligt

                      1 Reply Last reply
                      0
                      • J Offline
                        J Offline
                        JKY_VH
                        wrote on sidst redigeret af
                        #187

                        detalje, der "blot gør dagens nye resultater endnu mere imponerende." https://www.shareholders.dk/nyhed/novo-aktien-i-markant-stigning-efter-nye-data?utm_source=Aktionærens Nyhedsbrev&utm_campaign=be4509cbe1-20-07-2024_COPY_01&utm_medium=email&utm_term=0_bfc53fad21-be4509cbe1-90602917

                        1 Reply Last reply
                        0
                        • Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktør
                          wrote on sidst redigeret af
                          #188

                          Godmorgen 🙂

                          1 Reply Last reply
                          0
                          • R Offline
                            R Offline
                            Riis7
                            wrote on sidst redigeret af
                            #189

                            godmorgen:_)

                            1 Reply Last reply
                            0
                            • R Offline
                              R Offline
                              Riis7
                              wrote on sidst redigeret af
                              #190

                              1 Reply Last reply
                              0
                              • J Offline
                                J Offline
                                JKY_VH
                                wrote on sidst redigeret af
                                #191

                                Tak Riis7

                                1 Reply Last reply
                                0
                                • Helge_LarsenPI-redaktørH Offline
                                  Helge_LarsenPI-redaktørH Offline
                                  Helge_LarsenPI-redaktør
                                  wrote on sidst redigeret af
                                  #192

                                  Novo Nordisk’s Amycretin: A Glimpse into the Future of GLP-1 Weight Loss Treatments https://www.onthepen.com/post/novo-nordisk-s-amycretin-a-glimpse-into-the-future-of-glp-1-weight-loss-treatments?utm_campaign=e6280513-1189-4af4-8ad5-bb1922b1e58a&utm_source=so&utm_medium=mail&cid=713e80cd-1fa6-468e-90d7-68fd62c5df0e

                                  1 Reply Last reply
                                  0
                                  • K Offline
                                    K Offline
                                    koden
                                    wrote on sidst redigeret af
                                    #193

                                    Vi skal lige huske at studiet på Amycretin er et fase 1b/2a studie. Muligt de får lov at springe til fase 3. Men Cagrisema er vel stort set produktionsklar?

                                    1 Reply Last reply
                                    0
                                    • S Offline
                                      S Offline
                                      Svend_Skriver
                                      wrote on sidst redigeret af
                                      #194

                                      'Virker usandsynligt, at Novo Nordisk rammes af potentiel toldsats, siger analytiker' Søren Løntofts vurdering. NB: Indslaget fra 22/1 2025.
                                      https://nyheder.tv2.dk/live/udland/2025-01-18-trump-i-det-hvide-hus?entry=87246090-06e0-4e85-b939-4c550c316c73

                                      1 Reply Last reply
                                      0
                                      • K Offline
                                        K Offline
                                        koden
                                        wrote on sidst redigeret af
                                        #195

                                        nej medmindre at trump vil presse DK om Grønland. Men de har jo brug for wegovy, så næppe.

                                        1 Reply Last reply
                                        0
                                        • J Offline
                                          J Offline
                                          JKY_VH
                                          wrote on sidst redigeret af
                                          #196

                                          Fra Reuters "Veru said on Monday its
                                          experimental drug, in combination with Novo Nordisk's
                                          weight-loss treatment Wegovy, helped preserve muscle in older
                                          patients with obesity, meeting the main goal of a mid-stage
                                          study.
                                          The study was testing Veru's oral drug, enobosarm, in
                                          patients aged 60 and above. The drug targets androgen hormones,
                                          which play a role in body development and reproductive health.
                                          Patients who received the drug in combination with
                                          Wegovy lost 71% less lean muscle on average than

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper